^Lehner, Bernadette; Sandner, Beatrice; Marschallinger, Julia; Lehner, Christine; Furtner, Tanja; Couillard-Despres, Sebastien; Rivera, Francisco J.; Brockhoff, Gero et al. (2011). “The dark side of BrdU in neural stem cell biology: Detrimental effects on cell cycle, differentiation and survival”. Cell and Tissue Research345 (3): 313–28. doi:10.1007/s00441-011-1213-7. PMID21837406.
^ ab“Pharmacological evaluation of intravenous delivery of 5-bromodeoxyuridine to patients with brain tumors”. Cancer Res.44 (4): 1702–5. (1984). PMID6704976.
^ abKonishi, Teruaki; Takeyasu, Akihiro; Natsume, Toshiyuki; Furusawa, Yoshiya; Hieda, Kotaro (2011). “Visualization of Heavy Ion Tracks by Labeling 3'-OH Termini of Induced DNA Strand Breaks”. Journal of Radiation Research52 (4): 433–40. doi:10.1269/jrr.10097. PMID21785232.
^Kee, N; S Sivalingam; R Boonstra; J.M Wojtowicz (March 2002). “The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis”. Journal of Neuroscience Methods115 (1): 97–105. doi:10.1016/S0165-0270(02)00007-9. hdl:1807/357. PMID11897369.
^Eriksson, Peter; Ekaterina Perfilieva; Thomas Björk-Eriksson; Ann-Marie Alborn; Claes Nordborg; Daniel A. Peterson; Fred H. Gage (1998). “Neurogenesis in the adult human hippocampus”. Nature Medicine. 1313-1317 4 (11): 1313–1317. doi:10.1038/3305. PMID9809557.
^Fujimaki, Takamitsu; Masao Matsutani; Osamu Nakamura; Akio Asai; Nobuaki Funada; Morio Koike; Hiromu Segawa; Kouichi Aritake et al. (29 June 2006). “Correlation Between Bromodeoxyuridine- Labeling Indices and Patient Prognosis in Cerebral Astrocytic Tumors of Adults”. Cancer67 (6): 1629–1634. doi:10.1002/1097-0142(19910315)67:6<1629::AID-CNCR2820670626>3.0.CO;2-E. PMID2001552.
^Hoshino, Takao; Tadashi Nagashima; Judith Murovic; Ellen M. Levin; Victor A. Levin; Stephen M. Rupp (1985). “Cell Kinetic Studies of In Situ Human Brain Tumors With Bromodeoxyuridine”. Cytometry6 (6): 627–632. doi:10.1002/cyto.990060619. PMID2998714.
^Peterson, M. R.; Harrop, S. J.; McSweeney, S. M.; Leonard, G. A.; Thompson, A. W.; Hunter, W. N.; Helliwell, J. R. (1996). “MAD Phasing Strategies Explored with a Brominated Oligonucleotide Crystal at 1.65Å Resolution”. Journal of Synchrotron Radiation3 (Pt 1): 24–34. doi:10.1107/S0909049595013288. PMID16702655.